Skip to content

Observational study on the clinical efficacy of self formulated "Cihu Xiaotong decoction" in the treatment of acute stage of gouty arthritis with dampness heat toxin stasis syndrome

Observational study on the clinical efficacy of self formulated "Cihu Xiaotong decoction" in the treatment of acute stage of gouty arthritis with dampness heat toxin stasis syndrome

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400087356
Enrollment
Unknown
Registered
2024-07-25
Start date
2024-08-26
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gout

Interventions

control group (Basic treatment):None
observation group (Basic treatment + Cihu Xiaotong decoction):None

Sponsors

Southern Medical University Hospital of Integrater Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1),;Patients voluntarily participated in the study and signed the informed consent form; (2)Adults aged 18 to 70 years old, regardless of gender; (3)Those who meet both traditional Chinese and Western medicine diagnostic standards and insist on taking prescriptions, with complete syndrome differentiation and prescription records; (4)This gout attack lasted no more than 48 hours.

Exclusion criteria

Exclusion criteria: (1) Patients with chronic gouty arthritis or in the intermittent period of gout attacks; (2) Those with incomplete collection of data; (3) Those combined with other rheumatic and immune diseases, such as systemic lupus erythematosus, ankylosing spondylitis, Sjogren's syndrome, psoriatic arthritis, etc.; (4) Those combined with other serious systemic diseases, such as severe cardiovascular and cerebrovascular injuries, liver (ALT>=3ULN,TBiL>=2ULN)and kidney[eGFR<=60mL/(min·1.73m^2)] function impairment, etc.; (5) People with drug allergies; (6) Mentally ill patients and patients who are unable to cooperate; (7) Pregnant or breastfeeding women.

Design outcomes

Secondary

MeasureTime frame
Blood routine;liver function;renal function;Traditional Chinese Medicine Syndrome Score;ESR;CRP;blood uric acid;joint colour ultrasound;

Primary

MeasureTime frame
visual analogue scale;Degree of swelling;

Countries

China

Contacts

Public ContactChen Ensheng

Southern Medical University Hospital of Integrater Traditional Chinese and Western Medicine

chenensheng1@163.com+86 138 2446 9891

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026